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in clinicians’ knowledge and experience and types of surgery can influence peri-operative transfusion
practices. Sharing data on transfusion practices and recipients may improve patients’ care and imple-
mentation of Patient Blood Management (PBM). MATERIALS AND METHODS This was a multicen-
tre, prospective, observational, cross-sectional study that included 61 centres. Clinical and transfusion
data of patients undergoing major elective surgery were collected; transfusion predictors and patients’
outcomes were analysed. RESULTS Of 6,121 patients, 1,579 (25.8%) received a peri-operative transfu-
sion. A total of 5,812 blood components were transfused: red blood cells (RBC), fresh-frozen plasma
and platelets in 1,425 (23.3%), 762 (12.4%) and 88 (1.4%) cases, respectively). Pre-operative anaemia
was identified in 2,019 (33%) patients. Half of the RBC units were used by patients in the age group
45-69 years. Specific procedures with the highest RBC use were coronary artery bypass grafting (16.9%
of all units) and hip arthroplasty (14.9%). Low haemoglobin concentration was the most common in-
dication for intra-operative RBC transfusion (57%) and plasma and platelet transfusions were mostly
initiated for acute bleeding (61.3% and 61.1%, respectively). The RBC transfusion rate in study cen-
tres varied from 2% to 72%. RBC transfusion was inappropriate in 99% (n=150/151) of pre-operative,
23% (n=211/926) of intra-operative and 43% (n=308/716) of post-operative RBC transfusion episodes.
Pre-operative haemoglobin, increased blood loss, open surgery and duration of surgery were the main
independent predictors of intra-operative RBC transfusion. Low pre-operative haemoglobin concentra-
tion was independently associated with post-operative pulmonary complications. CONCLUSIONS These
findings identified areas for improvement in peri-operative transfusion practice and PBM implementation
in Turkey.
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Background - Patients’ demographic and epidemiological characteristics, 
local variations in clinicians’ knowledge and experience and types of surgery 
can influence peri-operative transfusion practices. Sharing data on transfusion 
practices and recipients may improve patients’ care and implementation of 
Patient Blood Management (PBM). 
Materials and methods - This was a multicentre, prospective, observational, 
cross-sectional study that included 61 centres. Clinical and transfusion data 
of patients undergoing major elective surgery were collected; transfusion 
predictors and patients’ outcomes were analysed. 
Results - Of 6,121 patients, 1,579 (25.8%) received a peri-operative transfusion. 
A total of 5,812 blood components were transfused: red blood cells (RBC), 
fresh-frozen plasma and platelets in 1,425 (23.3%), 762 (12.4%) and 88 
(1.4%) cases, respectively). Pre-operative anaemia was identified in 2,019 
(33%) patients. Half of the RBC units were used by patients in the age group 
45-69 years. Specific procedures with the highest RBC use were coronary 
artery bypass grafting (16.9% of all units) and hip arthroplasty (14.9%). 
Low haemoglobin concentration was the most common indication for 
intra-operative RBC transfusion (57%) and plasma and platelet transfusions 
were mostly initiated for acute bleeding (61.3% and 61.1%, respectively). 
The RBC transfusion rate in study centres varied from 2% to 72%. RBC 
transfusion was inappropriate in 99% (n=150/151) of pre-operative, 23% 
(n=211/926) of intra-operative and 43% (n=308/716) of post-operative RBC 
transfusion episodes. Pre-operative haemoglobin, increased blood loss, open 
surgery and duration of surgery were the main independent predictors of 
intra-operative RBC transfusion. Low pre-operative haemoglobin 
concentration was independently associated with post-operative pulmonary 
complications. 
Conclusions - These findings identified areas for improvement in 
peri-operative transfusion practice and PBM implementation in Turkey.
Keywords: Blood components, patient blood management, peri-operative, transfusion.
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INTRODUCTION
Transfusion practice for surgical patients has changed from replacing surgically lost blood 
with allogenic blood transfusions to implementing strategies that reduce transfusion 
requirements1,2. The new concept is Patient Blood Management (PBM), which is "the 
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haemoglobin concentration, optimize haemostasis 
and minimize blood loss in an effort to improve patient 
outcome"3. In this context, the decision of transfusion 
has become an important aspect of peri-operative 
patient care4. Despite several but in part contradictory 
peri-operative transfusion guidelines, it is challenging for 
an anaesthesiologist to implement transfusion guidelines 
because of local variations in clinicians’ knowledge and 
experience and characteristics of surgery5-9.  Analysing such 
factors in a representative sample of surgical transfusion 
recipients can elucidate areas for implementing restrictive 
transfusion guidelines and PBM4-11. 
The Turkish Society of Anaesthesiology and Reanimation 
conducted the Turkish National Perioperative Transfusion 
Study (TULIP-TS) to determine the areas for improvements 
in transfusion practice, to define practice standards, to 
collect data on future transfusion requirements and for 
health care planning, and to form a scientific basis for 
future research. 
The aim of the present study was to evaluate the 
peri-operative transfusion practices in patients 
undergoing elective major surgery; the incidence of and 
indications for peri-operative transfusion and the impact 
of transfusion on patients’ outcomes were analysed.
MATERIALS AND METHODS
The TULIP-TS was a multicentre, prospective, 
observational study involving patients undergoing major 
elective surgery. All patients received local standard care 
and no intervention was applied. The study was conducted 
in a 1-month period between April 2, 2018 and May 3, 2018. 
The ethics committee of the University of Health Sciences 
Diskapi Yildirim Beyazit Teaching Hospital approved 
the study (12/06/2017-39/12). Each participating centre 
provided local review board approval and consent was 
obtained from each patient. The study was registered at 
www.clinicaltrials.gov (NCT03468738).
Hospitals performing major surgery in at least one of the 
following specialties were invited to participate in the 
study: general, orthopaedic, urological, cardiovascular, 
thoracic, paediatric, gynaecological, obstetric, transplant 
surgery and neurosurgery. After initial evaluation of 
hospitals that voluntarily indicated their interest in taking 
part in the study, nine additional hospitals were invited to 
participate in order to achieve a geographical distribution 
across the country as well as to ensure hospital diversity.
Centres were selected on the basis of a pre-study 
survey. This survey included questions regarding the 
annual numbers of major surgical procedures and blood 
component utilisation in each study centre. The minimum 
expected enrolment rate of each centre was calculated 
accordingly.
Patients undergoing major elective surgical procedures 
were considered eligible. All age groups and both genders 
were included. The surgical procedures were predefined 
according to the Classification of Diagnostic, Therapeutic, 
and Surgical Procedures of the National Social Insurance 
Institution, in which every procedure has a unique code 
(Online Supplementary Content, Table SI)12. In order to avoid 
enrolment bias, all patients undergoing a certain surgical 
procedure were enrolled irrespectively of whether they 
received a transfusion. Emergency cases requiring surgery 
in less than 2 hours and patients admitted to the operating 
area through the emergency department were excluded.
The following data were collected: the patient’s 
characteristics, diagnosis, comorbidities, physiological 
parameters, surgical parameters, laboratory results 
(haemoglobin concentration, platelet count, and 
coagulation profile), anaesthesia management and 
monitoring, intra-operative PBM strategies (autologous 
blood donation, cell salvage, acute normovolaemic 
haemodilution, procoagulant drugs), transfusion-related 
data (indication [Online Supplementary Content, Table SII], 
blood components, and amount), estimated blood loss, 
urine output, intravenous f luids, unanticipated intensive 
care unit admission and prolonged duration of stay 
according to the local standard of care, post-operative 
adverse outcomes, and all-cause mortality at day 30 
after surgery. Comorbidity, physiological and surgical 
risk scores were determined for each patient13-15. The 
haemoglobin concentration on admission to hospital was 
defined as the pre-operative haemoglobin; this value was 
used to define pre-operative anaemia (<12 g/dL in females; 
<13 g/dL in males; <11 g/dL in pregnancy)16. The last 
measured haemoglobin concentration before red blood 
cell (RBC) transfusion was defined as the pre-transfusion 
haemoglobin. For RBC transfusions, the pre-transfusion 
haemoglobin values were considered as a measure of 
transfusion trigger. Post-transfusion haemoglobin 
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fresh-frozen plasma (FFP), and platelets (1 Unit [U] of 
aphaeresis platelet equals 5 U of random platelets). 
Inappropriate RBC transfusion was defined as RBC 
transfusion in patients with a haemoglobin concentration 
≥7 g/dL without active bleeding and/or the presence 
of co-morbid disease and/or physiological transfusion 
trigger6,7. Blood loss was estimated using both the 
blood absorbed in sponges and the blood aspirated 
into canisters during an operation. The European 
Perioperative Clinical Outcome definitions were used 
to define post-operative adverse outcomes including 
hypotension, new onset arrhythmia, angina, non-fatal 
cardiac arrest, acute myocardial infarction, congestive 
heart failure, cardiogenic pulmonary oedema, new 
onset anticoagulation, myocardial injury in non-cardiac 
surgery, acute kidney injury, thromboembolic-ischaemic 
events, infections, stroke, new neurological deficit, and 
pulmonary complications17. Mortality within 30 days 
of surgery was documented from the National Death 
Certification System. All patients were followed up for a 
1-month period. The drop-out criterion was withdrawal of 
a patient’s consent. 
The primary outcome was the incidence of peri-operative 
transfusion. Transfusion indications and the impact 
of transfusion on patients’ outcomes were the other 
outcomes.
Data collection
OpenClinica© open source software 3.3 (OpenClinica LLC, 
Waltham, MA, USA) was used for the data collection and 
management. Data were first collected on paper case report 
forms (CRF) and thereafter entered into the database. 
All CRF were completed by the study investigators. The 
investigators were given training regarding the study 
protocol, obtaining consent from patients, and using the 
database. Patient recruitment and data plausibility checks 
were performed daily. Independent query management, 
data cleaning, and source data verification provided 
high quality data. Enrolment bias was investigated by 
comparing the enrolment rate of each study centre with its 
minimum expected enrolment rate and by cross-checking 
the scheduled surgery lists of the study centre for eligible 
patients.
Statistical analysis
The Predictive Analytical Software statistics for Windows, 
version 18 (SPSS Inc., Chicago, IL, USA) was used for 
the analyses. Descriptive statistics were expressed as 
numbers (proportion) for categorical variables and as 
mean ± standard deviation, median (interquartile range) 
for numerical variables. In binary logistic regression 
multivariable analysis, potential predictive variables were 
included according to their clinical relevance and test 
requirements. The variables were checked for singularity 
and multicollinearity. Linearity assumption was checked 
by the Box-Tidwell test. The final model fit was tested 
using the Hosmer-Lemeshow test. Results were expressed 
as odds ratio (OR) and 95% confidence intervals (CI). All 
tests were two-tailed and an alpha significance level less 
than 0.05 was considered statistically significant. 
Sample size
In 2017, the blood component utilisation throughout 
the country was 2,453,051 U RBC, 1,263,462 U FFP, and 
540,217 U platelets (unpublished data, Ministry of Health, 
Turkey). According to the pre-study survey, 25% of these 
components were issued to the hospitals included in this 
study (RBC: 467,321 U, FFP: 457,219 U, and platelet: 96,928 U). 
Furthermore, based on the annual numbers of major 
operations performed in the study centres, the expected 
number of patients to be enrolled was 6,000. The results 
of our pilot study revealed a transfusion rate of 28%; 
accordingly, we assumed we would be able to collect data 
from over 1,500 transfused patients18.
Although data were collected from all age groups, as 
patients aged <18 years have unique features and surgical 
characteristics as well as anaemia definitions and 
transfusion indications, only data from adult patients are 
analysed here.
RESULTS
Sixty-one centres participated in the study: 32 university 
hospitals, 23 teaching hospitals, four private hospitals and 
two state hospitals. The hospital size ranged from 250 to 
1,300 beds. During the study period, 6,570 patients were 
assessed for eligibility, 79 patients did not consent to 
participate in the study, and 6,491 patients were recorded. 
The planned operations were not completed in 12 patients 
and 16 patients were lost during follow-up. Three patients 
were considered ineligible because their operations were 
performed within less than 2 hours of hospital admission 
(diagnosis of epidural haematoma). Eighty patients 
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violations; the number of patients recorded was less 
than the minimum expected enrolment rate and only the 
patients in whom transfusion occurred were recruited, 
which was considered an enrolment bias. Thus, the final 
analyses was based on 6,121 adult patients (Figure 1). The 
annual number of blood transfusions performed in the 
study centres accounted for one quarter of the nationwide 
blood component utilisation in 2017 and it is, therefore, 
considered that the results of this study can ref lect the 
peri-operative transfusion practice throughout the 
country. Blood components are prepared in accordance 
with the European Directorate for the Quality of 
Medicines and Healthcare19. This standardisation enables 
international comparison of the results. 
Features of the study population are summarised in 
Table I. The median (interquartile range) pre-operative 
haemoglobin concentration was 12.9 (11.6-14.1) g/dL and 
pre-operative anaemia was identified in 2,019 (33%) patients; 
anaemia was more common in males than in females (34.7% 
vs 32.0 %, p=0.02) and the incidence increased with age. 
During the peri-operative course, 1,579 (25.8%) 
patients received at least 1 unit of a blood component; 
a total of 5,812 blood components were transfused 
(Table II). A transfusion was given to 154 (9.8%) patients 
pre-operatively, 1,057 (66.9%) patients intra-operatively, 
and 889 (56.3%) patients post-operatively. There were more 
female transfusion recipients (52.6% vs 47.3%). The median 
(interquartile range) age of the transfusion recipients was 
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Table I - Characteristics, anaesthesia and surgical data of the patients transfused or not transfused in the peri-operative period



























CCI 0.67 ±1.11 0.95 ±1.27 0.57 ± 1.03
P-POSSUM 2.16 ± 5.9 4.87 ± 10.14 1.21 ± 2.76
SRS 2.38 ±2.71 3.92 ±3.83 1.85 ±1.92





























Abnormal coagulation profile 506 (8.4%) 222 (14.2%) 284 (6.4%)

















Pre-operative anaemia by age groups
18-44 yrs,  n=1,672
45-69 yrs,  n=1,609
70-79 yrs,  n=942

































































Controlled hypotension 626 (10.3%) 241 (15.4%) 385 (8.6%)
Values are mean ± standard deviation, median (interquartile range) or numbers (proportion). BMI: body mass index; ASA: American Society of Anaesthesiologists 
physical class; CCI: Carlson co-morbidity index;  P-POSSUM: Portsmouth physiological and operative severity score; SRS: Surgical risk scale; NOAC: novel oral 
anticoagulants; BUN: blood urea nitrogen; CRP: C-reactive protein. *In non-cardiac surgery.
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62 (52-70) years and the rate of receiving a transfusion 
was the highest in patients >80 years old (144/251, 57.3%) 
(Table II). A median of 2 (1-3) U of RBC, 2 (1-4) U of FFP 
and 4 (4-8) U of platelets were transfused per patient. 
Among transfused patients 861/1,579 (54.5%) cases received 
>1 U of RBC; the numbers of patients receiving each blood 
component and numbers of transfused RBC units by age 
groups are displayed in Figure 2. Cardiovascular/thoracic 
surgery was the surgical specialty with the highest RBC, 
FFP and platelet transfusion rate, 31.3%, 62.5% and 
65.0% respectively. The procedures with the highest RBC 
transfusion rate were coronary artery bypass graf ting 
(n=313/359, 87.2%) and in non-cardiac surgery vertebrae 
instrumentation for diagnosis of a malignancy (n=37/81, 
45.6%) (Table II).
The most common RBC transfusion indication was 
a "haemoglobin trigger", which was the case for all 
pre-operative RBC transfusions and 57.3% of 
intra-operative and 72.8% of post-operative RBC 
transfusions (Table II). The mean haemoglobin 
concentrations prior to a RBC transfusion were 
9.2±1.4 g/dL pre-operatively, 8.9±1.9 g/dL, intra-
operatively, and 8.8±1.3 g/dL post-operatively. The 
mean haemoglobin trigger in study centres  varied 
from 6.6±0.9 to 10.7±1.2 g/dL intra-operatively and from 
7.0±1.0 to 10.6±1.2 g/dL post-operatively (Figure 3). The mean 
haemoglobin concentrations after RBC transfusion were 
10.3±1.2 g/dL pre-operatively, 9.8±1.8 g/dL intra-operatively, 
and 9.7±1.3 g/dL post-operatively. Haemoglobin 
concentrations were measured af ter each RBC 
transfusion for 81.0% of the RBC transfusions. 
Transfusion indications for FFP were hypotension 
(36.2%), oozing (32.6%); surgical blood loss (30.4%) 
and guided by point-of-care coagulation testing (1.4%) 
intra-operatively, and oozing (49.4%), hypotension 
(20.5%) and surgical blood loss (11.8%) post-operatively. 
Transfusion indications for platelets were oozing (39.7%), 
surgical blood loss (19.0%) and guided by point-of-care 
testing (1.7%) intra-operatively, and oozing (44.7%) and 
surgical blood loss (26.3%) post-operatively.
The RBC transfusion rate in study centres varied from 3 to 
46% intra-operatively and from 2 to 72% post-operatively. 
According to our predefined criteria, RBC transfusion was 
inappropriate in 150 (99%) patients pre-operatively, in 211 
(23%) intra-operatively and in 308 (43%) post-operatively 
(Figure 3). The logistic regression analysis of the total RBC 
transfusions and inappropriate RBC transfusions in both 
the intra-operative and post-operative periods did not 
reveal an association between these (r=0.216, p=0.104 and 
r=0.207, p=0.125, respectively).
Patient-, procedure-, and anaesthesia-related factors 
associated with intra-operative RBC transfusions are 
presented in Table III. Independent risk factors for 
intra-operative RBC transfusion were age (OR: 1.025, 95% CI: 
1.019-1.031; p<0.001), body mass index (OR: 0.982, 95% CI: 
0.965-0.997; p=0.018), presence of coronary artery disease 
(OR 1.279, 95% CI: 1.019-1.606); p=0.034), presence of 
heart failure (OR 1.489, 95% CI: 1.066-2.101; p=0.023), 
Table I - Characteristics, anaesthesia and surgical data of the patients transfused or not transfused in the peri-operative period
(continued from previous page)




































Duration	of	surgery,	min 155.5 ± 102.6 214.9 (113.4 134.7 ±89.7
*Intra-operative	blood	loss,	mL 373.8 ±485.4 704.4 ±775.3 262.9 ±253.1
Values are mean ± standard deviation, median (interquartile range) or numbers (proportion).
BMI: body mass index; ASA: American Society of Anaesthesiologists physical class; CCI: Carlson co-morbidity index; P-POSSUM: Portsmouth physiological 
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Table II - Peri-operative transfusion data and Red blood cell transfusion indications
A.	Peri-operative	transfusion	data	of	the	study	population

































Transfused patients by age group
18-44 yrs, n=1,672
45-69 yrs,  n=1,609
70-79 yrs,  n=942



















Units transfused per patient
5,812 (100.0%)




2 (1-4)  
583 (10.0%)





































Transfused patients by surgical procedure*
CABG, n=359
CABG + valve surgery, n=36
Valve surgery, n=128
Vertebrae  - Instrumentation - Malign, n:81
Hip arthroplasty - Fracture, n=266
Hip arthroplasty - Coxarthrosis, n=265
Vertebrae - Instrumentation - Benign, n=207
Colectomy - Malign, n=285










































Haemoglobin trigger and physiological trigger**
Haemoglobin trigger and blood loss
Haemoglobin	trigger,	physiological	trigger	and	blood	loss
Blood loss and physiological trigger












































Inappropriate RBC transfusion ‡ 150 (99%) 211 (23%) 308 (43%)
Values are mean ± standard deviation, median (interquartile range) or numbers (proportion).
*The first seven procedures with the highest RBC transfusion rate are presented. There are patients in whom transfusion occurred in >1 period, with 
>1 component, and with >1 U. ** Physiological trigger includes hypotension, tachycardia, acidosis, high lactate levels.  † Decreased tissue oxygenation 
includes jugular venous oximetry and regional oxygen saturation. ‡Inappropriate transfusion = haemoglobin concentration ≥7 g/dL and without active 
bleeding and/or without the presence of comorbid disease and/ or physiological transfusion trigger.
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Figure 2 - Transfusion data by age groups
A: Number of blood components transfused in each age group; B: Number of red blood cell units transfused in each age group. 
RBC: red blood cells, FFP: fresh-frozen plasma. 
Figure 3 - Intra-operative and post-operative red blood cell transfusion rates and mean haemoglobin triggers in study 
centres
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Table III - Multivariate analyses
A.	Factors	associated	with	intra-operative	red	blood	cell	transfusion
Factors
Univariate analysis Multivariate analysis
OR	(95%	CI) p OR	(95%	CI) p
Patient-related factors
    Gender (male vs female) 1.747 (1.517-2.011) <0.001 1.025 (1.019-1.031) <0.001
    Age change per year increase 1.025 (1.020-1.029) <0.001 0.982 (0.965-0.997) 0.018
    BMI 0.961 (0.948-0.975) <0.001
    ASA change per class increase 1.954 (1.783-2.141) <0.001
    CCI change per class increase 1.644 (1.373-1.968) <0.001
    SRS 1.272 (1.241-1.304) <0.001
    P-POSSUM change per class increase 4.153 (3.569-4.840) <0.001
    Coronary artery disease 2.472 (2.080-2.938) <0.001 1.279 (1.019-1.606) 0.034
    Heart failure 2.999 (2.305-3.903) <0.001 1.489 (1.056-2.101) 0.023
    Stroke 1.921 (1.262-2.923) 0.002 - 0.733
    Malignancy 1.290 (1.020-1.630) 0.033 - 0.121
    Pre-operative haemoglobin decrease per 1 g/dL 1.329 (1.280-1.381) <0.001 1.471 (1.403-1.541) <0.001
    Pre-operative anaemia 2.819 (2.444-3.251) <0.001
    Presence of antiplatelet/anticoagulant drugs 2.290 (1.937-2.707) <0.001
    Presence of an abnormal coagulation profile* 2.404 (1.952-2.960) <0.001 1.447 (1.101-1.901) 0.008
    Presence of a coagulation disorder 4.839 (2.525-9.273) <0.001
    Presence of pre-operative RBC transfusion 2.703 (1.905-3,835) <0.001
    Pre-operative RBC transfusion per 1 unit increase 1.393 (1.184-1.638) <0.001
Procedure-related factors
    Amount of blood loss increase per 100 mL 1.364 (1.333-1.395) <0.001
    Blood loss more than 400 mL 10.796 (9.206-12.260) <0.001 8.677 (7.191-10.470) <0.001
    Duration of surgery increase per 1 min 1.008 (1.007-1.008) <0.001
    Duration of surgery more than 180 min 5.539 (4.778-6.421) <0.001 2.985 (2.468-3.610) <0.001
    Surgical technique (open vs other**) 5.708 (3.776-8.629) <0.001 3.266 (2.064-5.167) <0.001
Anaesthesia-related factors
    Use of haemostatic agents 2.098 (1.716-2.098) <0.001
    Anaesthesia method (general vs other†) 2.229 (1.853-2.683) <0.001
Hospital-related factors
    Type of hospital (university-teaching vs other‡) 1.335 (1.106-1.611) 0.003 - 0.160
    Size of hospital (>750 beds vs ≤750 beds) 1.324 (1.142-1.534) <0.001 - 0.057
Values are odds ratio and 95% confidence intervals. *Prothrombin time, activated prothrombin time, and international normalized ratio above institutional 
laboratory references. **Laparoscopic, robotic. †Neuro-axial block, peripheral block. ‡ state, private.
ASA: American Society of Anesthesiologists; CCI: Carlson co-morbidity index; SRS: Surgical risk score; P-POSSUM: Portsmouth physiological and operative 
severity score for the enumeration of morbidity and mortality; RBC: red blood celsl; CI: confidence interval. 
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Table III - Multivariate analyses (continued from previous page)
B.	Factors	associated	with	post-operative	pulmonary	complications
Factors
Univariate analysis Multivariate analysis
OR	(95%	CI) p OR	(95%	CI) p
Patient-related factors
    Gender (male vs female) 2.132 (1.473-3.085) <0.001 1.530 (1.003-2.253) 0.048
    Age change per year increase 1.039 (1.025-1.052) <0.001 1.030 (1.016-1.045) <0.001
    BMI 0.997 (0.964-1.032) 0.879
    ASA change per class increase 1.920 (1.578-2.335) <0.001
    CCI change per class increase 2.106 (1.471-3.014) <0.001
    SRS 1,157 (1,117-1,198) <0,001
    P-POSSUM change per class increase 2.727 (2.163-3.437) <0.001
    Coronary artery disease 2.988 (2.002-4.459) <0.001 1.581 (1.024-2.441) 0.039
    Heart failure 3.082 (1.739-5.464) <0.001
    Stroke 1.348 (0.422-4.304) 0.614 - 0.652
    Malignancy 1.254 (0.685-2.295) 0.463 - 0.937
    Pre-operative haemoglobin decrease per 1 g/dL 1.143 (1.040-1.256) 0.006 1.171 (1.064-1.289) 0.001
    Pre-operative anaemia 1.800 (1.246-2.600) 0.002
    Use of antiplatelet/anticoagulant drugs 1.868 (1.220-2.860) 0.004
    Presence of an abnormal coagulation profile* 1.937 (1.148-3.267) 0.013 - 0.250
    Presence of pre-operative RBC transfusion 2.614 (1.196-5.713) 0.016
    Pre-operative RBC transfusion per 1 unit increase 1.542 (1.157-2.054) 0.003
Procedure-related factors
    Amount of blood loss increase per 100 mL 1.042 (1.020-1.064) <0.001
    Blood loss more than 400 mL 2.934 (2.030-4.242) <0.001 2.025 (1.347-3.044) 0.001
    Duration of surgery increase per 1 min 1.004 (1.003-1.006) <0.001
    Duration of surgery more than 180 minutes 3.207 (2.212-4.650) <0.001 2.006 (1.321-3.045) 0.001
    Surgical technique (open vs other†) 1.396 (0.726-2.682) 0.317 - 0.771
Anaesthesia-related factors
    Presence of haemostatic agents 0.993 (0.530-1.859) 0.983
    Anaesthesia method (general vs other‡) 2.280 (1.359-3.825) 0.002
    Intra-operative crystalloid infusion (per liter) 1,400 (1,258-1,558) <0,001
    Intra-operative colloid infusion (per liter) 2,519 (1,623-3,910) <0,001
    Intra-operative blood transfusion (per unit) 1,334 (1,185-1,501) <0,001
    Use of intra-operative blood transfusion 3,686 (2,520-5,392) <0,001
Values are odds ratio and 95% confidence intervals. *Prothrombin time, activated prothrombin time, and international normalized ratio above institutional 
laboratory references. **Laparoscopic, robotic. †Neuro-axial block, peripheral block. ‡ state, private.
ASA: American Society of Anesthesiologists; CCI: Carlson co-morbidity index; SRS: Surgical risk score; P-POSSUM: Portsmouth physiological and operative 
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low pre-operative haemoglobin concentration, per 1 g/dL 
decrease (OR: 1.471, 95% CI: 1.403-1.541; p<0.001), presence 
of an abnormal coagulation profile (OR 1.447, 95% CI: 
1.101-1.901; p=0.008), blood loss >400 mL (OR: 8.677, 95% CI: 
7.191-10.470; p<0.001), duration of surgery >180 min 
(OR: 2.985, 95% CI: 2.468-3.610; p<0.001), and open surgical 
technique (OR: 3.266, 95% CI: 2.064-5.167; p<0.001).
Adverse outcomes following surgery were observed in 
371 (6.1%) patients (Table IV). The unadjusted rates of 
post-operative adverse outcomes and mortality were 
higher in patients who received a transfusion. The adverse 
outcome rate was 3.7% (n=229/6,121 patients) in transfused 
patients and 2.3% (n=142/6,121 patients) in non-transfused 
patients (p<0.001). The all-cause mortality rate at day 30 
was 1.4% (n=58/1,579 transfused patients and n=27/4,542 
non-transfused patients) (p<0.001). After adjusting for 
confounders, the regression models did not provide 
statistically significant explanatory power; a multivariate 
analysis could only be performed for the composite 
"post-operative pulmonary complications". Factors 
associated with an increased risk of post-operative 
pulmonary complications are presented in Table III; 
pre-operative low haemoglobin concentration was 
associated with post-operative pulmonary complications 
whereas intra-operative RBC transfusion was not.
DISCUSSION
This study provides detailed clinical data for a large 
number of surgical patients, comprising both transfusion 
recipients and non-recipients, and a description of 
transfusion practices and patients’ outcomes. 
Table IV - Univariate analysis of the post-operative outcomes of the transfused and non-transfused patients
Overall Transfused Non-transfused p
Mortality 85 (1.4%) 58 (0.9%) 27 (0.4%) <0.001
Unanticipated ICU admission 34 (0.6%) 19 (0.3%) 15 (0.2%) <0.001
PLOS 155 (2.5%) 84 (1.3%) 71 (0.1%) <0.001
Single organ outcomes
Pneumonia 39 (0.6%) 26 (0.4%) 13 (0.2%) <0.001
Pulmonary embolism 13 (0.2%) 5 (0.08%) 8 (0.1%) <0.001
Acute kidney injury 27 (0.4%) 15 (0.2%) 12 (0.1%) <0.001
Myocardial infarction 8 (0.1%) 6 (0.09%) 2 (0.03%) <0.001
Stroke 13 (0.2%) 8 (0.1%) 5 (0.08%) <0.001
Infection 130 (2.1%) 57 (0.9%) 73 (1.1%) <0.001
Composite outcomes
Major adverse cardiac event 33 (0.5%) 26 (0.4%) 7 (0.1%) <0.001
Pulmonary complications 116 (1.9 %) 68 (1.1%) 48 (0.7%) <0.001
Post-operative morbidity 103 (1.7%) 58 (0.9%) 45 (0.7%) <0.001
Values are numbers (proportion). ICU: intensive care unit; PLOS: prolonged length of stay according to local standard care;
Infection includes: infection source unknown, surgical site infection (superficial, deep, and organ/space), urinary tract infection, blood stream infection
Major adverse cardiac event includes: arrhythmia, angina, new requirement for anticoagulation, cardiogenic pulmonary oedema, non-fatal cardiac arrest, 
cardiac arrest, myocardial infarction, myocardial injury after non-cardiac surgery, congestive failure. Pulmonary complications include: pneumonia, 
pulmonary embolism, respiratory failure, respiratory infection, acute respiratory distress syndrome.
Post-operative morbidity includes: new requirement for oxygen or respiratory support, hypotension, ischaemia, arrhythmia, urinary catheter, increased 
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In the present study transfusion practice is evaluated 
throughout all three peri-operative periods because the 
decision to transfuse is made by different clinicians with 
presumably diverse indications in each stage. In general, 
anaesthesiologists are primary decision-makers during 
surgery, whereas surgeons make the decisions regarding 
transfusion before and after surgery.
We documented a high peri-operative incidence of 
transfusion. Even though the highest proportion of 
transfusions occurred intra-operatively; transfusions 
performed before and after surgery constituted almost an 
equal proportion of peri-operative transfusion. 
One of the important results of the TULIP-TS is that 
one-third of the study population had pre-operative 
anaemia. We used the World Health Organisation 
definition to detect anaemia. This definition is considered 
deficient because females have lower circulating blood 
volume and, therefore, the same amount of blood loss 
during similar surgery leads to a higher proportion of 
lost circulating blood volume compared to that in men20. 
Using a definition of anaemia of <13 g/dL for both sexes, 
a higher incidence of pre-operative anaemia could have 
been documented in females. 
The management of pre-operative anaemia is an integral 
aspect of PBM. Pre-operative anaemia increases the 
likelihood of RBC transfusion in surgical patients and 
is associated with adverse outcomes21. Iron deficiency is 
the most common cause of anaemia in surgical patients 
and can be treated with either oral or intravenous iron 
replacement depending on the timing of surgery20. 
Intravenous iron therapy is recommended prior to surgery 
as it both increases haemoglobin concentration and 
decreases the requirement for RBC transfusion22. 
Unfortunately, in our study population pre-operative 
anaemia was either left untreated or RBC transfusions 
were given, with a low haemoglobin concentration being 
the reason for all the pre-operative RBC transfusions. The 
mean pre-operative haemoglobin concentration that we 
determined suggests that the "historical 10 g haemoglobin 
rule" is still accepted among surgeons.
According to our results intra-operative RBC transfusions 
were triggered primarily by a haemoglobin threshold. 
Current guidelines suggest that RBC transfusion is 
indicated when haemoglobin concentration is <7 g/dL, 
can be administered depending on co-morbidities, 
intravascular volume and blood loss when haemoglobin 
concentration is 7-10 g/dL and is unnecessary when 
haemoglobin concentration is >10 g/dL, and a target 
haemoglobin concentration of 7-9 g/dL is recommended 
during active bleeding5-9. Adapting low haemoglobin 
thresholds for transfusion reduces RBC utilization20,22. 
Nevertheless, indications for intra-operative RBC 
transfusion are not clearly defined and the 7-10 g/dL 
haemoglobin concentration range, in particular, is left to 
clinicians’ discretion5-11. 
In the TULIP-TS the intra-operative haemoglobin trigger 
was mostly between 7-10 g/dL; however, a reason to 
justify all of these transfusions was not reported by the 
participants. These findings indicate that a restrictive 
transfusion strategy is not well adopted among 
anaesthesiologists. 
The appropriateness of RBC transfusion was assessed 
on the basis of a haemoglobin trigger (<7 g/dL) and the 
presence of active bleeding and/or a co-morbidity and/or 
indicators of impaired oxygenation to rationalise higher 
haemoglobin triggers. Accordingly, over one-fifth of 
intra-operative RBC transfusion episodes were considered 
inappropriate. 
We examined the potential predictors of intra-operative 
RBC transfusion. A low pre-operative haemoglobin 
concentration also appeared as an independent risk factor 
for intra-operative RBC transfusion; the probability of 
intra-operative RBC transfusion increased by 1.5-fold 
for each 1 g/dL decrease in pre-operative haemoglobin 
concentration. The analyses also included adjustments 
for the patients’ co-morbidity, physiological and surgical 
risk indices which include vital signs, laboratory values, 
drugs and the magnitude of surgery as parameters. 
The results show that not the severity of illness but 
the presence of coronary arterial disease and heart 
failure were independently associated with increased 
transfusion requirement. The study centres were 
included in this analysis according to their healthcare 
provision levels and size; we found that neither the 
type nor the size of the hospital was a predictor of 
intra-operative RBC transfusion. This result is in accordance 
with previous studies reporting wide variability between 
hospitals in blood component transfusion irrespective of 
hospital type or surgical case volume23.
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of intra-operative RBC transfusion, and a physiological 
transfusion trigger -hypotension- was the subsequent 
reason for initiating a RBC transfusion. Physiological 
triggers based on signs of impaired global or regional 
oxygenation can be used to guide transfusion, provided 
that the volume status and anaesthesia is optimised24. 
Physiological triggers should replace arbitrary 
haemoglobin values to determine individual transfusion 
requirements24. 
Post-operative RBC transfusions were also mainly 
triggered by a haemoglobin threshold. We evaluated 
inappropriate post-operative RBC transfusions separately 
and found a higher rate compared to that in the 
intra-operative period, suggesting that the surgeons are 
even more reluctant to use restrictive haemoglobin triggers.
Of particular interest with regards to inappropriate RBC 
use, we documented that inappropriate pre-operative 
RBC transfusions accounted for over 10% of all RBC 
transfusions; 23% of the intra-operative and 43% of the 
post-operative RBC transfusion episodes were considered 
inappropriate. These data show the potential extent of 
decrease in RBC use after implementation of PBM.
The main indication for FFP and platelet transfusions 
was "blood loss" and specifically "oozing" both in the 
intra-operative and post-operative periods. Although this 
type of blood loss suggests coagulopathy, the FFP and 
platelet transfusions were not accompanied by coagulation 
testing. Oozing and post-operative bleeding also suggests 
that bleeding disorders or drugs that compromise the 
coagulation pathway may be involved25. Our results did not 
support these assumptions; however, the results showed 
that the presence of an abnormal coagulation profile 
increased the risk of intra-operative RBC transfusion. 
Oozing itself is a subjective definition; blood transfusion 
because of oozing without coagulation testing actually 
shows that a clinician’s knowledge, experience and personal 
preferences affect transfusion decisions. 
The utilisation of blood conservation strategies during 
the study period was very low. One exception to this 
observation was the use of tranexamic acid. Tranexamic 
acid was used in 9.5% of the overall study population; 
however, considering that the majority of the study 
population underwent orthopaedic procedures it could be 
commented that the usage is still low.
One of the main drivers of the change in transfusion 
practices is the relation of transfusion with adverse 
outcomes, morbidity and mortality26-29.
Our results show higher rates of mortality and other 
adverse outcomes except for infections in transfused 
patients. Despite these results, since the incidence of 
adverse outcomes in the study population was low, the 
explanatory power of multivariate analysis was not 
sufficient to document a relationship between transfusion 
and adverse outcomes. We did document an increased risk 
of post-operative pulmonary complications in patients 
with a low pre-operative haemoglobin concentration.
Previous studies on transfusion in surgical patients are 
limited to certain surgical procedures2,30. Our study is 
comparable to the European Transfusion Practice and 
Outcome Study, although only RBC-transfused patients 
were included and only intra-operative transfusion 
was evaluated in that study31. The TULIP-TS is more 
comprehensive since the results indicate that the rate 
of transfusions outside the operating theatre might 
approximate the rate of those performed intra-operatively. 
The prospective design is a strength of this study which 
enabled transfusion indications to be evaluated in relation 
to all patients’ conditions, in contrast to registries which 
associate the transfusion indication with only one diagnosis32. 
Moreover, this study included all patients undergoing major 
surgery and, therefore,  the case mix of this sample can 
be regarded as representative of the surgical population. 
We report data from both transfusion recipients an non-
recipients. Despite providing data from a large number 
of surgical patients, the short duration of recruitment is a 
limitation because certain surgical procedures may have 
been unequally represented in the study period. Another 
limitation is that post-operative transfusion was only 
monitored on the first day following surgery; some patients 
in the study population may have received transfusions in 
the following days, which could have affected the outcomes. 
Finally post-transfusion haemoglobin concentration was 
not recorded after each transfusion so the intended goal of 
transfusion could not be determined. 
In this comprehensive evaluation of current peri-operative 
transfusion practices in Turkey we identified blood use 
that is non-compliant with evidence-based transfusion 
practice. We also found that PBM strategies are only 
applied individually, and transfusion decisions are mainly 
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Implementing a nationwide PBM programme may improve 
our transfusion practice1. Specific areas for improvement 
pointed out by our results are: pre-operative anaemia 
management, adapting low haemoglobin thresholds, 
increasing the utilisation of autologous transfusion 
methods and tranexamic acid when appropriate and 
increasing the use of coagulation testing20,33-38. This study 
indicated that the priority specialties for implementing 
PBM strategies are cardiovascular surgery and 
orthopaedics.  
We also detected wide variations between study centres, 
especially in the haemoglobin triggers, RBC transfusion 
rates and inappropriate RBC transfusion rates. We 
consider this variation as a result of transfusion decisions 
being made by a single and different clinician in each 
peri-operative period. There is clear need to reduce 
blood use variability among hospitals and clinicians. Our 
results indicate that a formal training plan for surgeons 
and anaesthesiologists should be developed. Also 
practice standards in accordance with local legislation 
and infrastructure are needed. Involving surgeons in 
these efforts may improve success39. The performance 
of hospitals and physicians should be audited according 
to these standards. Establishing clinical transfusion 
management committees at hospitals may solve problems 
regarding transfusions based on clinicians’ preferences. 
Both the transfusion rates and the haemoglobin triggers 
that we have determined constitute a reference point 
and can be used to assess the effectiveness of our PBM 
programmes in future audits.
We plan to present these results to the Ministry of Health 
and pursue legal enactment of implementation of a 
national PBM programme, acceptance of PBM strategies 
for hospital quality assessments, and constitution of 
clinical transfusion committees.   
CONCLUSIONS
In Turkey, 25.8% of the patients presenting for elective 
major surgery received blood transfusion. The indications 
for RBC transfusion included haemoglobin threshold, 
presence of bleeding, and subsequent physiological 
triggers of transfusion. 
Pre-operative anaemia was detected in more than 
one-third of the patients presenting for surgery. A low 
pre-operative haemoglobin concentration was not only 
an independent risk factor for intra-operative RBC 
transfusion but was also associated with a higher risk of 
post-operative pulmonary complications.
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